FDA Authorizes First Non-Tobacco Flavored E-Cigarettes with Advanced Age-Gating Technology

The U.S. Food and Drug Administration (搜索)搜索该词条 has authorized the marketing of four Glas electronic nicotine delivery systems (搜索)搜索该药品 (ENDS) through the premarket tobacco product application pathway, marking a significant milestone as the first authorization of non-tobacco and non-menthol flavored e-cigarette products. The authorized products include Classic Menthol, Fresh Menthol, Gold, and Sapphire pods, each containing 50mg/ml (5%) of tobacco-derived nicotine查看药品详情.

Breakthrough Age-Gating Technology

The FDA's authorization hinges on Glas's innovative device access restriction technology, which the agency determined effectively mitigates youth access to the products. The system requires users to verify their age and identity with a government-issued ID and pair the device with a smartphone via Bluetooth. Once verified, the device will not operate if separated from the phone, and the accompanying app conducts random biometric check-ins to periodically confirm the registered user is the one using the device.

"By helping to prevent youth use, device access restrictions are a potential game changer," said Bret Koplow, Ph.D., J.D., acting director of the FDA's Center for Tobacco Products. "This technology is also an indication of the role innovation may serve in the effort to protect young people from threats posed by nicotine查看药品详情 use and addiction while helping to enable availability of an expanded array of flavored options for adults who smoke."

Rigorous Scientific Review Process

The FDA's scientific review found that the applicant sufficiently demonstrated that most adults aged 21 and older successfully completed age verification and found the device use instructions and age-verification software easy to understand and activate, while youth and young adults could not. This represents a new pathway for demonstrating that non-tobacco flavored products meet the public health standard through effective age-gating technology.

Addressing Public Health Crisis

The authorization comes as smoking (搜索)搜索该疾病 remains the leading preventable source of chronic disease (搜索)搜索该疾病 and premature death in the United States. According to the FDA, one in five deaths last year resulted from cigarette smoking, with more than 25 million Americans still smoking combustible cigarettes. The agency emphasizes that these individuals "deserve better, less harmful alternatives."

Strict Marketing and Monitoring Requirements

To further mitigate potential youth use, the marketing orders require Glas to ensure its advertising is carefully targeted to adults ages 21 and older, limiting youth exposure to promotional activities. The company must track, measure, and report to the FDA the effectiveness of its youth prevention measures and provide analyses of the demographics reached by its advertising and promotional activities.

The FDA will closely monitor how these products are marketed and may suspend or withdraw authorization if the company fails to comply with statutory or regulatory requirements, or if there is a notable increase in youth use or evidence that the products' benefits no longer outweigh the risks.

Expanding Authorized Product Portfolio

With these four new authorizations, the FDA has now approved 45 ENDS products for legal marketing in the United States. These products represent the only e-cigarettes that may currently be lawfully sold in the country. The agency maintains that there is no safe tobacco product and emphasizes that those who do not currently use tobacco products should not start, and youth should never use tobacco products.

The authorization is specific to these four Glas products only and does not apply to any other products from the company. Glas Inc. (搜索)搜索该词条, based in Inglewood, California, had previously received FDA authorization for its G2 Device and Blonde Tobacco pod containing 50 milligrams/milliliters of nicotine查看药品详情.